焦點科技(002315.SZ):擬繼續使用不超5億元自有閒置資金進行投資理財
格隆匯 1 月 28日丨焦點科技(002315.SZ)公佈,公司於2019年12月13日召開的第四屆董事會第二十三次會議上審議通過了《關於授權使用自有閒置資金進行投資理財的議案》,同意公司在保障正常運營和資金安全的基礎上,使用公司及其全資、控股子公司不超過人民幣5億元的自有閒置資金進行投資理財,有效期為自獲董事會授權之日(2019年12月13日)起一年。
現原授權已到期,為提高資金使用效率,保證資金使用連續性,公司及其全資、控股子公司擬繼續使用不超過5億元的自有閒置資金進行投資理財。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.